Hazardous drugs shouldn’t be the hidden cost of healthcare; one company is making the invisible visible to protect those who heal us.

Hospitals and clinics are designed for healing, yet they often harbor an invisible threat: the migration of hazardous chemotherapy drugs. While these potent medications are vital for treatment, studies show they frequently travel far beyond the pharmacy, contaminating doorknobs, keyboards, and nursing stations where they pose significant risks to healthcare workers and patients. Despite the critical nature of this issue, the industry has long lacked an effective, standardized solution for monitoring and mitigating such surface contamination across diverse clinical settings.

ChemoGLO addresses this gap through a specialized approach rooted in pharmacy, analytical chemistry, and pharmacology. Dr. Bill Zamboni explains how their technology moves beyond guesswork, allowing facilities to identify specific hazardous drug residues and implement targeted management solutions. By providing clinicians with the tools to detect and neutralize these materials on a molecular level, ChemoGLO is not just cleaning surfaces—it is actively preventing long-term occupational exposure and ensuring that the healthcare environment remains safe for everyone who steps inside.